HOME >> BIOLOGY >> NEWS
New research suggests therapeutic approach for autoimmune diseases

BAR HARBOR, ME Researchers at The Jackson Laboratory have identified a novel therapeutic target for treating autoimmune disease.

In research published in the May Journal of Clinical Investigation, a team headed by Senior Staff Scientist Derry Roopenian discovered that a normally functioning protein, referred to as FcRn, plays an important role in promoting arthritis, a common form of autoimmune disease.

In total, 80 known autoimmune diseases strike 10 million Americans, and constitute one of the leading causes of disability among women. Women comprise 75 percent of patients with autoimmune disease.

The immune system, composed of white blood cells, provides the major line of defense against infectious microorganisms. Plasma cells are white blood cells that secrete proteins called antibodies. These antibodies normally circulate throughout the body, looking for infectious organisms. The antibodies attach to the microorganisms and promote their destruction.

However, in some individuals, too many antibodies are produced, and many of them can "go bad" in that they attach to normal tissues rather than the foreign invaders. These antibodies are referred to as autoantibodies, and they are thought to promote many forms of autoimmune diseases, including lupus, rheumatoid arthritis, myasthenia gravis, immune thrombocytopenic purpura (ITP) and autoimmune thyroiditis, to name a few. So, Dr. Roopenian and his colleagues sought to devise methods to reduce the number of autoantibodies available for tissue destruction.

The research team focused on FcRn, whose normal job is to preserve antibodies in the circulation. "While a good thing in normal individuals, FcRn could be working too efficiently in patients with lupus and rheumatoid arthritis," explains Dr. Roopenian. "The consequence is the maintenance of dangerously high levels of autoantibodies."

To test this idea, Dr. Roopenian used mice that normally develop arthritis caused
'"/>

Contact: Joyce Peterson
joyce@jax.org
207-288-6058
Jackson Laboratory
3-May-2004


Page: 1 2

Related biology news :

1. Leader in cancer treatment and prevention research honored
2. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
3. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
4. Belgian researchers explore revolutionary approach to angiogenesis
5. Award winning researchers reveal potential new role for Glivec
6. New research shows plants can shuffle and paste gene pieces to generate genetic diversity
7. 16 APS exercise research highlights, from reduced flu mortality to proteomics & obesity
8. Gene chips research in cotton could lead to superior variety
9. Groundbreaking research could ignite new solutions to heat transfer in nano-devices
10. New hydrothermal vents discovered as South Pacific Odyssey research begins
11. University of Alberta researcher looks for clues to mysterious disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/6/2019)... ... June 05, 2019 , ... ... exclusive financial advisor to Pathologists Bio-Medical Laboratories (PBM) on its recent acquisition by ... pathology platform that provides services to more than one dozen hospitals and surgery ...
(Date:6/4/2019)... ... 04, 2019 , ... Most preclinical EEG visualization platforms offer ... usually based on variations of amplitude, frequency or spike train detection. In the ... to the complexity and variability of the signal, and automation tools are used ...
(Date:5/31/2019)... ... May 29, 2019 , ... FileWave, ... and mobile, announces the launch of version 13.1. The new version extends FileWave’s ... API, and supports Apple’s spring release functionality. Version 13.1 builds on FileWave’s version ...
Breaking Biology News(10 mins):
(Date:5/31/2019)... ... 29, 2019 , ... For many years, the primary forms of cancer treatment ... therapies. Advances in immuno-oncology have led to the advent of Chimeric Antigen Receptor T ... cell receptors known as “CARs”. The CAR enables the final product to produce chemicals ...
(Date:5/31/2019)... ... May 30, 2019 , ... Object ... announce the strategic acquisition of Metabiologics, Inc., a globally recognized leader in the ... ownership and commercialization rights to a full spectrum of botulinum neurotoxins, as well ...
(Date:5/21/2019)... ... May 21, 2019 , ... DuPont Nutrition & Biosciences (DuPont) ... Africa Brewing Conference dedicated to sharing brewing knowledge, strengthening relationships and discussing best ... supported through a partnership with “Ethiopia Invest”, will run through May 23, 2019, ...
(Date:5/14/2019)... EGG HARBOR TOWNSHIP, N.J. (PRWEB) , ... May ... ... premier manufacturer of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, ... a completely new Heliumleak.com company website. The redesigned website aims to improve LDA’s ...
Breaking Biology Technology:
Cached News: